About the Authors
- Matthias Rupp
-
* E-mail: mrupp@mrupp.info (MR); gisbert.schneider@pharma.ethz.ch (GS)
Current address: Department of Chemistry, University of Basel, Basel, Switzerland.
Affiliation Department of Chemistry and Applied Biosciences, Eidgenössische Technische Hochschule (ETH), Zürich, Switzerland
- Matthias R. Bauer
-
Affiliation Department of Pharmaceutical Chemistry, Eberhard Karls University, Tübingen, Germany
- Rainer Wilcken
-
Current address: MRC LMB, Cambridge, United Kingdom.
Affiliation Department of Pharmaceutical Chemistry, Eberhard Karls University, Tübingen, Germany
- Andreas Lange
-
Affiliation Department of Pharmaceutical Chemistry, Eberhard Karls University, Tübingen, Germany
- Michael Reutlinger
-
Affiliation Department of Chemistry and Applied Biosciences, Eidgenössische Technische Hochschule (ETH), Zürich, Switzerland
- Frank M. Boeckler
-
Affiliation Department of Pharmaceutical Chemistry, Eberhard Karls University, Tübingen, Germany
- Gisbert Schneider
-
* E-mail: mrupp@mrupp.info (MR); gisbert.schneider@pharma.ethz.ch (GS)
Affiliation Department of Chemistry and Applied Biosciences, Eidgenössische Technische Hochschule (ETH), Zürich, Switzerland
Competing Interests
GS is a scientific consultant to the pharmaceutical industry and a shareholder of inSili.com LLC, Zurich, Switzerland, and AlloCyte Pharmaceuticals Ltd., Basel, Switzerland. The authors have declared that no other competing interests exist.
Author Contributions
Conceived and designed the experiments: MRu MRB RW FMB GS. Performed the experiments: MRu MRB RW AL MRe. Analyzed the data: MRu MRB RW AL MRe FMB GS. Wrote the paper: MRu MRB FMB GS.